Sabaa International Company for Pharmaceutical and Chemical Industry

E£5.52As of Sun 8 Nov 2026, 12:00 UTC
EGX:SIPCHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 30.98%
Div yield —
ROE (3.61%)
Pharmaceutical Preparations
Beta (5Y) 0.48
PE TTM —
TSR TTM 84.00%
Mkt cap E£1.380B
ROIC (2.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£6.01
8.82%
(82.96%)
Hold 3|2|1|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
0.10
0.11
0.11
0.11
(0.34%)
10.75%
8.05%
2.75%
RevenueE£M
107.8
111.4
113.1
114.7
2.00%
1.11%
1.76%
3.53%
Peers (US$23.57M)
Cap (US$)
PE
124.0M
14.37x
83.40M
27.22x
58.02M
13.45x
Capital
TTM
5Y
10Y
Leveragex
0.056
(0.202)
(0.148)
EBIT/Intx
0.444
0.106
0.113
Own earn%
55.34
24.85
19.51
Sh yield%
41.35
14.08
13.94
Owners
Insiders/Inst%
3.88
24.18
Short interest%
5.88
SBC / revenue%
3.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
27–34
$1 testx
0.0
Incr. ROIC%
0